About Dr. (Col) Ranga Rao Rangaraju
Dr. (Col) Ranga Rao Rangaraju is a highly distinguished Medical Oncologist with over four decades of exemplary service in both the Armed Forces Medical Services and leading civilian hospitals.He brings vast experience in managing a wide spectrum of solid cancers and hematological malignancies in adult and pediatric patients. Dr. Ranga Rao is renowned for his expertise in chemotherapy, targeted therapy, immunotherapy, and palliative care. He has a keen interest and proven track record in establishing state-of-the-art cancer centers, building multidisciplinary teams, and implementing standardized treatment protocols. His commitment extends beyond clinical practice to research, teaching, and fervent advocacy for cancer awareness and patient support.
OPD Schedule Of Dr. (Col) Ranga Rao Rangaraju
Consultation Fees Rs. /-
Paras Hospitals, Gurgaon
- MBBS, Jawaharlal Nehru Medical College, Ajmer (1977)
- MD (Internal Medicine), Armed Forces Medical College (AFMC), Pune (1984)
- DM (Medical Oncology), Cancer Institute (WIA), Chennai (1993)
- Clinical Exchange Program, MD Anderson Cancer Centre, Houston, USA
- Visitor, Dana Farber Cancer Institute, Boston, USA
- Visitor, Royal Marsden Hospital, London, UK
- Awarded the Vishisht Seva Medal (VSM) by the President of India for distinguished service.
- Solid Tumors (Adult & Pediatric)
- Head & Neck Cancer
- Lung Cancer
- Uro-Gynaecological Cancers (Bladder, Kidney, Prostate, Ovarian, Cervical, Endometrial)
- Bone Cancer
- Lymphoma
- Breast Cancer
- Gastrointestinal Cancers
- Medical Oncology
- Haemato-Oncology (Leukemia, Myeloma)
- Palliative Oncology
- Systemic Chemotherapy (including high-dose and weekly protocols)
- Targeted Therapy
- Immunotherapy
- Hormonal Therapy
- Supportive Care Management
- Palliative Care Planning & Delivery
- Chairman, Paras Cancer Centres, Paras Health, Gurugram (Present)
- Senior Director, Oncology Services & Medical Oncology, Max Institute of Cancer Care, Max Super-Speciality Hospital, Shalimar Bagh, New Delhi (Nov 2014 – Dec 2019)
- Director, BLK Cancer Centre, BLK Super Speciality Hospital, New Delhi (Apr 2011 – Nov 2014)
- Senior Consultant & Professor, Medical Oncology, Rajiv Gandhi Cancer Institute & Research Centre, New Delhi (Feb 2006 – Oct 2009)
- Head of Department & Senior AdvisOr, Oncology, Army Hospital (Research & Referral), New Delhi (Feb 2002 – Jan 2006)
- Specialist in Medicine and Medical Oncologist, Armed Forces Medical Services (Various locations including Mumbai, Kolkata, Pune) (1977 – 2002)
- Professor of Medical Oncology (RGCI, Army Hospital R&R)
- Postgraduate Teacher in Medicine and Medical Oncology
- Involved in numerous clinical trials and research projects.
- Extensive experience organizing CMEs and teaching sessions.
- Instrumental in establishing state-of-the-art cancer centers (BLK, contributed significantly at Max, Paras).
- Established the first Day Care Chemotherapy Centre and computerized OPD at Army Hospital (R&R).
- Founding member and driving force behind the Armed Forces Oncology Group (AFOG) and its treatment protocols.
- Pioneered research in weekly chemotherapy regimens for specific cancers in India.
- Led various committees (Medical Audit, Management, IT Project) at RGCI.
- Organized numerous cancer awareness camps and programs for the public and physicians.
- Mentored numerous oncologists and healthcare professionals.
- Lifetime Achievement Award, Indian Cancer Congress (ICC)/Indian Society of Medical and Paediatric Oncology (ISMPO) (2023)
- Lifetime Achievement Award, Oncology Forum Annual Meeting, New Delhi (2023)
- Lifetime Achievement Award, Indian Cooperative Oncology Network (ICON), Hyderabad (2020)
- Lifetime Achievement Award, MTI (2020)
- Vishisht Seva Medal (VSM), President of India (2006)
- Air Marshal Ajit Nath Guru Shanti Devi Award (1997)
- Lt Gen R S Hoon Award (1996, 1994)
- Best Paper Award MJAFI (1996)
- Best Original Article Award MJAFI (1995)
- Col K K Gupta Memorial Gold Medal (for topping MD Internal Medicine) (1984)
- Sheetal Sahai Oration, Cancer Institute & Research Centre, Gwalior (2019)
- Sushruta Award (Best Innovative Department), Max Health Care (2018)
- CEO’s Award, Max Health Care (2017)
- 2nd Best Poster Award, Merck Serono Oncology Summit, Hong Kong (2012)
- Delivered over 110 lectures and presentations nationally and internationally.
- Indian Perspective On 17th St. Gallen: Customizing Local and Systemic Therapies for Indian Women with Breast Cancer (2022)
- Real-World Experience in Toxicity with Bevacizumab in Indian Cancer Patients (2021)
- Survival Outcomes with Docetaxel, Oxaliplatin, and Fluorouracil Regimen for the Treatment of Metastatic Gastric Adenocarcinoma: A Single‑Center Experience (2020)
- Cardiotoxicity in patients on trastuzumab in HER2-positive breast cancer -A retrospective analysis from a center in North India (2020)
- Impact of Molecular Subtypes on Survival Outcomes in Breast Cancer : Indian perspective (2020)
- Pazopanib Monotherapy Is Active in Relapsed and Refractory Metastatic Gastroesophageal Adenocarcinoma and Can Produce Durable Response (2020)
- Genetic testing for hereditary breast and ovarian cancer in Indian population: A single institutional study (2019)
- Immunotherapy-induced interstitial lung disease: Cases report (2019)
- Patient-Centred Care: Dr. Ranga Rao firmly believes in a patient-centric approach, involving patients and their families in decision-making. He emphasizes clear communication, empathy, and addressing the holistic needs of the patient, including psychological and social support. Dr. Rao is a strong advocate for a multidisciplinary approach, ensuring collaboration between medical, surgical, and radiation oncologists, pathologists, radiologists, palliative care specialists, and support staff to provide comprehensive cancer care. He excels in building and leading cohesive, high-performing oncology teams.
- Technology & Innovation: He stays abreast of the latest advancements in oncology, incorporating evidence-based practices, including cutting-edge targeted therapies, immunotherapy, and precision medicine where appropriate. He champions the use of technology for better patient management, evident in his initiatives like computerized OPD systems.